Latest Innovation News

EZZ Life Science Holdings marked a pivotal quarter with the launch of its EZZDAY brand in the US, a significant Southeast Asia distribution agreement, and expanded domestic retail presence, driving a 46% jump in customer receipts.

Adveritas Limited reports a robust 62% increase in annualised recurring revenue to $10.47 million and a record doubling of full-year cash receipts, backed by a strategic $8.5 million institutional placement to accelerate growth in the US and new verticals.

Neometals has reported a maiden Mineral Resource Estimate for its Ironclad gold deposit at Barrambie and signed a non-binding MoU with Rio Tinto to advance its lithium processing technology, alongside progress in battery recycling plant commissioning.

Victory Metals has produced a 94% total rare earth oxide product enriched in heavy rare earths from its North Stanmore project, marking a first for Australian clay-hosted deposits and setting a new industry benchmark.

Elevate Uranium prepares to ship its U-pgrade™ Pilot Plant to Namibia, aiming to validate its innovative uranium beneficiation process through a large-scale trial processing 60 tonnes of ore.

ikeGPS reports a robust 29% increase in annual platform subscription revenue exit run rate for 1Q FY26, reiterating strong FY26 growth guidance and securing A$18 million in fresh capital to fuel expansion and new product development.

MEC Resources has boosted its investment in Advent Energy, navigates ongoing PEP-11 permit legal challenges, and highlights promising developments in clean hydrogen production.

FinTech Chain Limited has requested suspension of its shares from ASX trading to enable its removal from the official list, marking a significant shift for the fintech company.

Epsilon Healthcare has emerged from voluntary administration with a stronger balance sheet, securing refinancing and preparing to launch its new pharmacy platform. Operational stability and strategic initiatives signal a turning point for the healthcare group.

Richmond Vanadium Technology has paused parts of its feasibility study and approval processes in response to a prolonged downturn in vanadium prices, focusing instead on metallurgical innovation and cash conservation.

Anatara Lifesciences has received nearly $1 million from the Australian Government’s R&D tax incentive, providing a vital capital injection to advance its Anti-Obesity pre-clinical studies.

PainChek Limited has raised A$7.5 million through a strongly supported placement to accelerate its US market entry following anticipated FDA clearance and expand its innovative AI pain assessment technology internationally.